Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Kamada Ltd. Director's Dealing 2026

Mar 22, 2026

6874_rns_2026-03-22_cab313e6-2a7c-4331-a4a6-ecfdeff48326.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

E

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person* Orlev Chaime 2. Date of Event Requiring Statement (Month/Day/Year) 03/16/2026 3. Issuer Name and Ticker or Trading Symbol KAMADA LTD [ KMDA ]
(Last) (First) 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below)
6 DERECH EILOT ST.
(Street)
GANEI L3 5591166
TIKVA
(City) (State) (Zip)
Table I – Non-Derivative Securities Beneficially Owned
--- --- --- ---
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares 11,633 D
Table II – Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
--- --- --- --- ---
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)
Date Exercisable Expiration Date Title Amount or Number of Shares
Options to purchase Ordinary Shares(1) 05/28/2024 11/28/2029 Ordinary Shares 22,500
Options to purchase Ordinary Shares(1) 05/28/2025 11/28/2029 Ordinary Shares 22,500
Options to purchase Ordinary Shares(1) 02/28/2026 08/28/2028 Ordinary Shares 22,500
Options to purchase Ordinary Shares(1) 05/28/2026 11/28/2029 Ordinary Shares 22,500
Options to purchase Ordinary Shares(1) 10/22/2026 10/22/2035 Ordinary Shares 22,500
Options to purchase Ordinary Shares(1) 05/28/2027 11/28/2029 Ordinary Shares 22,500
Options to purchase Ordinary Shares(1) 10/22/2027 10/22/2035 Ordinary Shares 22,500
Options to purchase Ordinary Shares(1) 10/22/2028 10/22/2035 Ordinary Shares 22,500
Options to purchase Ordinary Shares(1) 10/22/2029 10/22/2035 Ordinary Shares 22,500

Explanation of Responses:

  1. These options to purchase ordinary shares are exercisable using a net-exercise method
  2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

/S/ Chaime Orlev

** Signature of Reporting Person

03/16/2026

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

  • If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.